Envista Holdings Corporation (NYSE:NVST) Given Consensus Recommendation of “Hold” by Analysts

Envista Holdings Corporation (NYSE:NVSTGet Free Report) has been assigned an average recommendation of “Hold” from the sixteen analysts that are currently covering the stock, Marketbeat reports. Two analysts have rated the stock with a sell rating, eight have given a hold rating, five have issued a buy rating and one has given a strong buy rating to the company. The average 1 year price objective among brokerages that have covered the stock in the last year is $21.5385.

Several equities research analysts recently issued reports on NVST shares. Mizuho set a $19.00 price objective on Envista in a research note on Monday, November 3rd. Evercore ISI reiterated an “outperform” rating on shares of Envista in a report on Friday, October 31st. Weiss Ratings restated a “sell (d)” rating on shares of Envista in a report on Monday, December 8th. Barclays started coverage on shares of Envista in a research report on Monday, December 8th. They set an “overweight” rating and a $24.00 price objective on the stock. Finally, Robert W. Baird set a $27.00 target price on shares of Envista in a research report on Friday, October 31st.

Check Out Our Latest Report on NVST

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the company. Alliancebernstein L.P. raised its stake in shares of Envista by 1,985.1% during the 1st quarter. Alliancebernstein L.P. now owns 4,550,789 shares of the company’s stock worth $78,547,000 after purchasing an additional 4,332,541 shares in the last quarter. Holocene Advisors LP bought a new position in Envista during the second quarter valued at approximately $43,936,000. Norges Bank bought a new position in Envista during the second quarter valued at approximately $40,229,000. Dimensional Fund Advisors LP lifted its stake in Envista by 24.0% in the first quarter. Dimensional Fund Advisors LP now owns 8,387,297 shares of the company’s stock valued at $144,760,000 after acquiring an additional 1,625,206 shares during the last quarter. Finally, Franklin Resources Inc. grew its position in Envista by 16.7% in the second quarter. Franklin Resources Inc. now owns 8,956,572 shares of the company’s stock worth $175,011,000 after acquiring an additional 1,284,767 shares in the last quarter.

Envista Trading Down 0.8%

Envista stock opened at $21.96 on Monday. Envista has a 52 week low of $14.22 and a 52 week high of $22.68. The company has a debt-to-equity ratio of 0.47, a quick ratio of 2.02 and a current ratio of 2.37. The firm has a market capitalization of $3.61 billion, a price-to-earnings ratio of 244.04, a P/E/G ratio of 1.08 and a beta of 1.02. The company has a 50 day moving average price of $20.17 and a 200 day moving average price of $20.14.

Envista (NYSE:NVSTGet Free Report) last announced its earnings results on Wednesday, October 29th. The company reported $0.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.27 by $0.05. The company had revenue of $669.90 million for the quarter, compared to the consensus estimate of $639.49 million. Envista had a net margin of 0.58% and a return on equity of 5.90%. The company’s revenue was up 11.5% on a year-over-year basis. During the same period in the previous year, the business earned $0.12 EPS. Research analysts forecast that Envista will post 1 EPS for the current year.

About Envista

(Get Free Report)

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.

See Also

Analyst Recommendations for Envista (NYSE:NVST)

Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.